T1	Participants 1334 1394	randomized 836 cases in placebo and 835 in amoxycillin group
T2	Participants 1059 1071	Participants
T3	Participants 1441 1448	placebo
T4	Participants 1468 1479	amoxycillin
T5	Participants 1567 1590	placebo and amoxycillin
T6	Participants 1688 1705	placebo treatment
